US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Pharmaceuticals Etf

73.57

+0.89001.22%

Post-market: 73.900.3300+0.45%16:40 EDT

Volume:97.23K

Turnover:7.13M

Market Cap:584.90M

PE:28.49

High:73.63

Open:73.06

Low:73.06

Close:72.68

52wk High:74.35

52wk Low:45.80

Shares:7.95M

Float Shares:7.95M

Volume Ratio:0.80

T/O Rate:1.22%

Dividend:0.33

Dividend Rate:0.46%

EPS(TTM):2.58

EPS(LYR):-0.1280

ROE:25.89%

ROA:0.40%

PB:2.57

PE(LYR):-574.69

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BMO starts Exelixis at Market Perform into patent cliff

AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape

HENLIUS Initiates First Patient Dosing in China for Phase 1 Study of Cetuximab Biosimilar HLX05-N in Metastatic Colorectal Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/XPH"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XPH\",,,,,undefined,":{"symbol":"XPH","market":"US","secType":"STK","nameCN":"Spdr S&P Pharmaceuticals Etf","latestPrice":73.57,"timestamp":1787688000000,"preClose":72.68,"halted":0,"volume":97225,"hourTrading":{"tag":"盘后","latestPrice":73.9,"preClose":73.57,"latestTime":"16:40 EDT","volume":66,"amount":4872.12,"timestamp":1787690400190,"change":0.33,"changeRate":0.004486,"amplitude":0.004486},"delay":0,"changeRate":0.012245459548706471,"floatShares":7950270,"shares":7950270,"eps":2.581957,"marketStatus":"Post-Mkt","change":0.89,"latestTime":"08-25 19:20:04 EDT","open":73.06,"high":73.63,"low":73.06,"amount":7134558.630375,"amplitude":0.007843,"askPrice":80.46,"askSize":100,"bidPrice":66.63,"bidSize":100,"shortable":3,"etf":1,"ttmEps":2.581957,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":72.68,"sharesOutstanding":5750270,"nav":72.821767,"aum":578952709.31,"dividendRate":0.004552,"bidAskSpread":0.002551,"postHourTrading":{"tag":"盘后","latestPrice":73.9,"preClose":73.57,"latestTime":"16:40 EDT","volume":66,"amount":4872.12,"timestamp":1787690400190,"change":0.33,"changeRate":0.004486,"amplitude":0.004486},"volumeRatio":0.79615,"impliedVol":0.1992,"impliedVolPercentile":0.9004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XPH\",,,,,undefined,":{"symbol":"XPH","floatShares":7950270,"roa":"0.40%","roe":"25.89%","lyrEps":-0.128016,"volumeRatio":0.79615,"shares":7950270,"dividePrice":0.3349,"high":73.63,"amplitude":0.007843,"preClose":72.68,"low":73.06,"week52Low":45.8,"pbRate":"2.57","psRate":"307.74","week52High":74.345,"institutionHeld":0,"latestPrice":73.57,"eps":2.581957,"divideRate":0.004552,"volume":97225,"delay":0,"ttmEps":2.581957,"open":73.06,"prevYearClose":56.01,"prevWeekClose":72.8,"prevMonthClose":68.06,"prevQuarterClose":66.27,"fiveDayClose":72.45,"twentyDayClose":69,"sixtyDayClose":58.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XPH\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XPH","amount":0.059045,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2026-03-23","symbol":"XPH","amount":0.060954,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-25"},{"date":"2025-12-22","symbol":"XPH","amount":0.113024,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XPH","amount":0.102634,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XPH","amount":0.095872,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.059917,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.091273,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.026956,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.085023,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.07227,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XPH\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660492411","title":"BMO starts Exelixis at Market Perform into patent cliff","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492411?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:30","pubTimestamp":1787085023,"startTime":"0","endTime":"0","summary":"BMO Capital initiated coverage of Exelixis (EXEL) with a Market Perform rating and $54 price target Exelixis is anchored by cabozantinib, a “durabl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LU2272731600.USD","IHE","BK4585","FTXH","LU2272731782.SGD","LU2322448791.USD","PPH","LU2322448957.HKD","BBH","LU2272731865.HKD","SYNB","MEDI","RSPH","RXD","IYH","GSKH","LU1992135399.USD","APXH","FXH","MEDX","LU2473716301.USD","JDOC","FBT","XPH","BK4532","BME","BK4207","PJP","EXEL","PBPH","RXL","LU1992135472.HKD","IE00B5TLWC47.USD","AZNH","BMO","PTH","BK4588","FHLC","TRUH","BK4139","TMED","CURE","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167771958","title":"AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape","url":"https://stock-news.laohu8.com/highlight/detail?id=1167771958","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167771958?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:33","pubTimestamp":1785713585,"startTime":"0","endTime":"0","summary":"AstraZeneca PLC (AZN.US) has been in early-stage discussions about acquiring Bristol-Myers Squibb (BMY.US), a move that could create one of the world's largest pharmaceutical companies, according to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","LU0321505439.SGD","LU2242646821.SGD","LU2417539215.USD","IE00B5TLWC47.USD","LU0225771236.USD","FTXH","PILL","LU1571399168.USD","IEHS","LU2456880835.USD","LU1323610961.USD","LU1032466523.USD","LU0320765992.SGD","LU2272731782.SGD","LU1868837300.USD","LU1670710588.SGD","LU2322448957.HKD","LU0310800379.SGD","IHE","BK4588","LU1670710661.SGD","IE00BJT1NW94.SGD","LU2596442595.SGD","AZNH","JHMH","LU2089984988.USD","BK4007","IE00BFTCPJ56.SGD","LU1093756168.USD","LU0096364046.USD","LU0114720955.EUR","LU1291159041.SGD","LU1093756325.SGD","LU2272731600.USD","LU1670711040.USD","AZN","LU2462157665.USD","LU1868836591.USD","BMY","LU1992135399.USD","LU2133065610.SGD","LU0289739699.SGD","BK4532","BK4568","LU1670711123.USD","IE00B2B36J28.USD","LU1267930573.SGD","LU2237443549.SGD","LU1868836914.USD","LU0128525929.USD","LU0306806265.USD","PPH","BK4534","CURE","LU2360032135.SGD","LU2237443382.USD","LU1992135472.HKD","LU2473716301.USD","LU0109394709.USD","LU0306807586.USD","LU2125154778.USD","LU1983299246.USD","LU2322448791.USD","IE0009355771.USD","LU0882574055.USD","LU0985481810.HKD","LU2237443895.HKD","LU1261432733.SGD","LU2468319806.SGD","IE00BSNM7G36.USD","MEDI","LU1829250122.USD","RXD","RXL","LU2242652126.USD","LU1883839398.USD","LU2125154935.USD","LU2237443465.HKD","SYNB","LU0061475181.USD","LU1718418525.SGD","XPH","LU1585245621.USD","LU2272731865.HKD","LU0225284248.USD","FHLC","XBIX","LU1868837136.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU0058720904.USD","IE0002141913.USD","LU1989771016.USD","LU0708994859.HKD","LU0432979614.USD","LU0889565916.HKD","LU1074936037.SGD","LU1868836757.USD","LU0267386448.USD","LU0029864427.USD","LU2237443978.SGD","BK4581","LU0321505868.SGD","LU0456855351.SGD","IE00BFXG1179.USD","LU1430594728.SGD","BK4559","LU0868494617.USD","FXH","IE00B3T34201.USD","BK4585","LU0237698245.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122606361","title":"HENLIUS Initiates First Patient Dosing in China for Phase 1 Study of Cetuximab Biosimilar HLX05-N in Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1122606361","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122606361?lang=en_us&edition=fundamental","pubTime":"2026-07-08 17:32","pubTimestamp":1783503169,"startTime":"0","endTime":"0","summary":"HENLIUS (ASX: 02696) has announced that the first patient in China (excluding Hong Kong, Macau, and Taiwan) has been dosed in a Phase 1 clinical study of its self-developed cetuximab injection...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2272731782.SGD","LU2322448957.HKD","LU1992135472.HKD","HK0000320223.HKD","PPH","XPH","LU1992135399.USD","HK0000306701.USD","LU2473716301.USD","IE00B5TLWC47.USD","LU2272731865.HKD","HK0000306685.HKD","BK1161","HK0000165453.HKD","LU2322448791.USD","IBB","02696","LU2272731600.USD","HK0000320264.USD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XPH\",params:#limit:6,delay:false,,,undefined,":[]}}